Tata Projects augments hospital infrastructure with 2,304 beds across India for COVID-19 patients

"As one of the fastest growing and most admired infrastructure companies in India, we felt the need to use our expertise in executing large and complex urban and industrial infrastructure projects towards augmenting, upgrading the nation's hospital network," Tata Projects Chief Strategy Officer Himanshu Chaturvedi said in a statement.

PTI

May 23, 2020 / 18:33 IST

Engineering firm Tata Projects on Saturday said it is augmenting hospital infrastructure with 2,304 beds at multiple locations across India to treat COVID-19 patients.

"As one of the fastest growing and most admired infrastructure companies in India, we felt the need to use our expertise in executing large and complex urban and industrial infrastructure projects towards augmenting, upgrading the nation's hospital network," Tata Projects Chief Strategy Officer Himanshu Chaturvedi said in a statement.

Today, the company is proud that its teams of engineers, technicians and workers are working tirelessly towards strengthening the fight against COVID-19, he added.

"We believe that our support in the fight against COVID-19 will further help in once again accelerating India's progress at the earliest,” Chaturvedi said.

Recently, at Mumbai's KEM Hospital, Tata Projects transformed two wards encompassing 65 beds and specialised medical equipment so that it can handle more serious coronavirus cases.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show